Metabolic evaluation of urolithiasis.
The relatively simple scheme described here should become part of the urologist's stone evaluation plan. It allows for the rapid identification of the metabolic disorders and the prompt implementation of appropriate therapy. With a stone remission rate of 70 to 90 per cent and a reduction in the stone formation rate of 88 to 100 per cent, an overwhelming incentive exists to master this evaluation scheme.
Case Western Reserve University School of Medicine, Cleveland, Ohio.
A
A
Seftel
M I
MI
Resnick
D002118:Calcium / Q000032:analysis; D003553:Cystine / Q000032:analysis; D006801:Humans; D008274:Magnesium / Q000032:analysis; D017616:Magnesium Compounds; D008659:Metabolic Diseases / Q000150:complications; D010710:Phosphates / Q000032:analysis; D000069877:Struvite; D014527:Uric Acid / Q000032:analysis; D014545:Urinary Calculi / Q000032:analysis / Q000209:etiology / Q000628:therapy
D017616:Magnesium Compounds; D010710:Phosphates; D014527:Uric Acid; D003553:Cystine; D000069877:Struvite; D008274:Magnesium; D002118:Calcium